[ad_1]
Unlike many European countries, including Germany, the US has not yet approved the AstraZeneca corona vaccine. It is cheaper and easier to store than other preparations, but there are always concerns about possible side effects.
Now, American epidemic expert Anthony Fauci has commented on the substance. He believes that the United States will not need the AstraZeneca vaccine even if it is approved in the United States. Among other things, Fauci advises the White House on issues related to the crown.
The director of the National Institute of Allergy and Infectious Diseases told Reuters: “My general opinion is that, given the contractual relationships we have with various companies, we have enough vaccine to meet all of our needs without AstraZeneca to claim.”
In Germany, the substance of the Swedish-British group is re-administered after a forced break. However, the federal government decided Tuesday to inoculate the vaccine only in people over 60 years of age.
The background for this is thrombosis, particularly among younger women. With 2.7 million doses of AstraZeneca administered, 31 suspected cases of so-called cerebral vein thrombosis were reported. Younger people in vaccination groups one and two could “decide, together with the vaccinating physician, at the physician’s discretion and with an individual risk analysis after careful information, to want to be vaccinated with AstraZeneca,” the decision said.
After the new age recommendation for the AstraZeneca corona vaccine went into effect, the Standing Commission on Immunization recommended a different vaccine for a second vaccination for younger people who had been vaccinated. Those under the age of 60 should receive one dose of the Biontech / Pfizer or Moderna vaccine after twelve weeks instead of the second dose of the AstraZeneca vaccine, the panel announced Thursday.
At SPIEGEL, the head of the Permanent Commission on Vaccination, Thomas Mertens, commented on the changing recommendations of his panel of experts regarding the AstraZeneca vaccine. “The Paul Ehrlich Institute responsible for security surveillance in Germany had recognized a very clear signal to which Stiko had to react,” Mertens said. He does not see any damage to the image of the vaccination campaign. “The current situation shows that the security system in Germany works.”
Now it depends on redistribution so as not to jeopardize the vaccination rate. »In Germany there are enough people over 60 who want to get vaccinated against Covid-19 and have not yet been vaccinated. You can get the AstraZeneca vaccine. So you don’t have to do without vaccine doses, ”Mertens says.
UK Authority: Benefits Outweigh Vaccine
New figures are available in the UK on the risks of using the vaccine. Local supervisory authorities reported a total of 30 cases that were affected by rare blood clots after the use of the AstraZeneca vaccine. This is 25 more cases than previously reported.
The UK Medicines and Healthcare Products Regulatory Agency says it has not received such reports of blood clotting after using the BioNTech and Pfizer vaccines. The health authority said the benefits of the AstraZeneca vaccine that they believed would outweigh the potential risk of blood clots.
